The downregulation of cGAS-STING in diverse tumor cells may be closely linked to epigenetic modifications, offering a novel theoretical foundation for reactivating the cGAS-STING pathway to enhance anti-tumor immune responses. The gene discussed is CGAS; the disease is neoplasm.